Steven Sobel
Optometrist · Orlando, FLNPI 1467489864
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 98.0% of the total across 194 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 15.0% — the pattern of someone who eats at a lot of different presentations. Among optometrist clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 194 payments — averaging $35.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$1K
- Coopervision Inc.$1K
- Bausch & Lomb, A Division Of Bausch Health US, LLC$655
- Oyster Point Pharma, Inc.$564
- Bausch & Lomb Americas Inc.$557
- AbbVie$513
- plus $3K from 18 others
Across 28 payments — averaging $36.43 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Notal Vision, Inc.$1K
What the payments were for
- Food & beverage$6,71998%
- Education$250%
- Entertainment$1132%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 26 | $1,030 |
| Coopervision Inc. | 28 | $1,022 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 12 | $655 |
| Oyster Point Pharma, Inc. | 21 | $564 |
| Bausch & Lomb Americas Inc. | 16 | $557 |
| AbbVie(2 entities) | 7 | $513 |
| Harrow Eye, LLC | 16 | $376 |
| Kala Pharmaceuticals, Inc. | 14 | $318 |
| Sun Pharmaceutical Industries Inc. | 12 | $265 |
| Optos, Inc. | 4 | $246 |
| LKC Technologies, Inc. | 2 | $216 |
| Tarsus Pharmaceuticals, Inc. | 7 | $179 |
| Novartis | 5 | $169 |
| Johnson & Johnson Vision Care, Inc. | 5 | $154 |
| Shire North American Group Inc | 2 | $140 |
| Dompe US, Inc. | 4 | $102 |
| Notal Vision, Inc. | 3 | $88 |
| Optovue, Inc. | 1 | $76 |
| Eyevance Pharmaceuticals LLC | 3 | $44 |
| Biotissue Holdings Inc. | 2 | $44 |
| Visionix USA, Inc | 1 | $40 |
| Johnson & Johnson Surgical Vision, Inc. | 1 | $21 |
| Carl Zeiss Meditec USA, Inc. | 1 | $20 |
| Sight Sciences, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$6,857 in reported general payments places this provider in the 90th percentile of 3,166 optometrist providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 21 | $22,588 |
| Latanoprost | 72 | $647 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 15 | $359 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieRestasis | $513 | $22,58821 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 3,166 optometrist providers in Florida.
Other optometrist in Orlando
- Kerry GieddOrlando$136K
- Norman HerskovichOrlando$60K
- Marie Seide-JustinOrlando$28K
- James HoffmanOrange Park$795K
- April JasperWest Palm Beach$553K
- Nora CothranLargo$505K
- Michael SluskyNorth Port$384K
- Katie SpearDefuniak Springs$361K
- Karen HoffmanOrange Park$282K
- Ashley RothMiami Beach$261K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.